News from parexel international corporation A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 26, 2015, 09:00 ET

PAREXEL Names Maykin Ho to Board of Directors

 PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that its Board of...

Aug 13, 2015, 10:00 ET

PAREXEL Receives CEO Cancer Gold Standard Accreditation

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that the CEO Roundtable on...

Aug 05, 2015, 17:51 ET

PAREXEL International Reports Fourth Quarter And Fiscal Year 2015 Results; Confirms Previous Revenue And Adjusted EPS Guidance For Fiscal Year 2016

Fourth Quarter Fiscal Year 2015 Results (compared to Fourth Quarter Fiscal Year 2014) - Adjusted earnings per share of $0.79, up 21.5%;...

Jul 21, 2015, 07:00 ET

PAREXEL Launches Next Generation Analytics Capabilities Within Perceptive MyTrials® Platform

 PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today launched the next generation of...

Jul 09, 2015, 07:00 ET

PAREXEL Expands Model-Based Drug Development Offering

 PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced expanded services and...

Jul 07, 2015, 09:00 ET

PAREXEL International Announces Date Of Fourth Quarter And Fiscal Year 2015 Earnings Release And Conference Call

 PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for the Fourth Quarter and Fiscal Year 2015 on Wednesday,...

Jun 23, 2015, 16:01 ET

PAREXEL International Issues Earnings Guidance In Conjunction With Investor Day

In conjunction with its Investor Day being held tomorrow, PAREXEL International Corporation (Nasdaq: PRXL) has updated its forward-looking guidance...

Jun 18, 2015, 07:00 ET

PAREXEL Launches Next Generation Data-Driven Monitoring Capabilities Within Perceptive MyTrials® Solution

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today launched next generation risk-based...

Jun 17, 2015, 09:00 ET

PAREXEL Invites Public To Listen To Live Webcast Of Its Investor Day June 24, 2015

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it will provide a live...

Jun 15, 2015, 09:00 ET

PAREXEL Executive Honored With 2015 DIA Global Connector Award

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that Alberto Grignolo, PhD,...

Jun 08, 2015, 09:00 ET

PAREXEL Experts To Discuss Key Drug Development Insights At DIA 2015 Annual Meeting

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that several of its experts...

May 27, 2015, 07:00 ET

PAREXEL Enhances ClinPhone® RTSM Service to Simplify and Expedite Randomization and Trial Supply Management for Clinical Studies

 PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced enhancements to its...

May 26, 2015, 10:00 ET

PAREXEL International To Present At Goldman Sachs Healthcare Conference

 PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Goldman Sachs Healthcare Conference in...

May 04, 2015, 10:00 ET

PAREXEL International to Present at UBS Healthcare Conference

PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the UBS Healthcare Conference on Monday, May 18,...

Apr 29, 2015, 16:02 ET

PAREXEL International Reports Third Quarter Fiscal Year 2015 Results

PAREXEL International Corporation (NASDAQ: PRXL) today reported financial results for the third quarter of Fiscal Year 2015, which ended on March...

Apr 24, 2015, 09:00 ET

PAREXEL Honored With 2015 Clinical Innovator Of The Year Award From Partnerships In Clinical Trials

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that Partnerships in...

Apr 13, 2015, 11:00 ET

PAREXEL Wins IABC 2015 Gold Quill Merit Award for Digital Communications

 PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that it has been awarded a...

Apr 08, 2015, 07:00 ET

PAREXEL Strengthens Commitment To Global Biopharmaceutical Workforce With New PAREXEL Academy Programs

 PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced three new academic...

Mar 31, 2015, 07:00 ET

PAREXEL Launches LIQUENT InSight® 6.0 Regulatory Information Management Platform

 PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today introduced the latest version of...

Mar 26, 2015, 09:00 ET

PAREXEL Announces Execution of Definitive Agreement to Acquire Quantum Solutions India, Strengthening Leadership In Pharmacovigilance Services

PAREXEL International Corporation (Nasdaq: PRXL), a global clinical research organization, announced today that the Company has signed a definitive...